Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia - Druker, BJ; Talpaz, M; Resta, DJ; Peng, B; Buchdunger, E; Ford, JM; Lydon, NB; Kantarjian, H; Capdeville, R; Ohno-Jones, S; Sawyers, CL (N Engl J Med, 2001)